Results 111 to 120 of about 88,076 (273)

Multidisciplinary Strategies for Targeting Tumor Dormancy in Breast Cancer Therapeutics: Hallmarks, Mechanism, and Approaches

iMetaMed, Volume 2, Issue 2, June 2026.
Clinical phases and classification of breast tumor dormancy. Tumor dormancy is described as the period after treatment until residual tumor cells become detectable as relapsing disease in clinic. During the period of clinical tumor dormancy, tumor mass dormancy and cellular dormancy may coexist.
Shu Chen, Hui Chen, Vijaya Raghavan, Jing Huang, Jin Wang   +4 more
wiley   +1 more source

Immunotherapeutical potential of DISC-HSV and OX40L in cancer

, 2004
Several vectors, viral and bacterial, have been developed over the past few years for means of generating an effective anti-tumor immune response. We have developed and studied a “model for immunotherapy” using a viral vector DISC-HSV, which efficiently ...
Robert C Rees, Selman A. Ali, Assudani, DP, Murrium Ahmad, Geng Li, Ahmad, M, Li, G, Deepak P. Assudani, Ali, SA, Rees, RC   +9 more
core   +1 more source

Humoral and cellular immune responses to mouse mammary tumor virus (MMTV) in experimental animal models (review)

, 1984
Mouse mammary tumor virus (MMTV) has been implicated in the etiology of mouse mammary tumors although genetic, hormonal and environmental factors appear to be involved in the mechanism of carcinogenesis.
Lopez, D M
core   +1 more source

Vacuolization as a Novel Approach to Cancer Therapy

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 6, June 2026.
This review discusses the novel strategy of inducing vacuole formation in cancer cells using small molecules, that induce nonapoptotic cell death mechanisms, such as paraptosis, oncosis, autophagy, and methuosis, and its potential in overcoming resistance to apoptosis‐based cancer therapies.
Mariah Pasternak, Noor Hussein, Veronica Piedra, Saloni Malla, Chandrabose Karthikeyan, Haneen Amawi, Harish Rajak, Charles R. Ashby Jr., R. Jayachandra Babu, Amit K. Tiwari   +9 more
wiley   +1 more source

Characterization of mouse mammary tumor virus expression in animals and tissue culture.

, 1988
Characterization of mouse mammary tumor virus expression in animals and tissue ...
Denis Rene. Henrard (7984568)
core  

CD133 Shapes Extracellular Vesicle Cargo and Angiogenic Function in Basal‐Like Triple‐Negative Breast Cancer

Journal of Extracellular Vesicles, Volume 15, Issue 6, June 2026.
ABSTRACT Extracellular vesicles (EVs) are central mediators of tumour‐stroma communication, yet the mechanisms governing their biogenesis and functional cargo remain poorly understood. Here, we identify CD133 (Prominin‐1), selectively expressed in basal‐like triple‐negative breast cancer (BL‐TNBC) cells, acts as a key organizer of EV production and ...
Mireia Gomez‐Duro, Ptissam Bergam, Sara Sanchez‐Redondo, Florent Dingli, Alix Zhou, Alain Joliot, Mengliang Ye, Marta Hergueta‐Redondo, Lucas Alves Tavares, Damarys Loew, Thierry Dubois, Lorena Martin‐Jaular, Hector Peinado, Graça Raposo, Gisela D'Angelo   +14 more
wiley   +1 more source

Increased Level of Serum Wingless-Type Mouse Mammary Tumor Virus Integration Site Family Member 5a in Patients with Cutaneous Lichen Planus

Journal of Inflammation Research, 2022
Jianwen Ren, Xiaoying Ning, Dingwei Zhang, Yanfei Zhang Department of Dermatology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xian, Shaanxi Province, People’s Republic of ChinaCorrespondence: Yanfei ZhangDepartment of Dermatology, The ...
Ren J, Ning X, Zhang D, Zhang Y
doaj  

Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus

, 1981
Lymphocytes from BALB/cCrgl mice react to mouse mammary tumor virus-associated antigen(s) when tested in in vitro blastogenic transformation assays. These mice have a low incidence (less than 1%) of spontaneous mammary tumors and are free from complete ...
Charyulu, V, Lopez, D M, Sigel, M M
core  

Interplays between mouse mammary tumor virus and the cellular and humoral immune response

, 1999
Mouse mammary tumor virus has developed strategies to exploit the immune response. It requires vigorous immune stimulation to achieve efficient infection.
MacLennan, I C, Finke, D, Antoine Attinger, Daniela Finke, Sonia Vacheron, Sandie Schmid, Vacheron, S, Toellner, K M, Schmid, S, Wehrli, N, Scarpellino, L, Xenarios, I, Hans Acha-Orbea, Nathalie Wehrli, Sanjiv A. Luther, Ioannls Xenarios, Kai-Michael Toellner, Attinger, A, Leonardo Scarpellino, Ian C. M. MacLennan, Luther, S A, Acha-Orbea, H   +21 more
core   +1 more source

Organoids: From Bench to Bedside Applications

MedComm, Volume 7, Issue 6, June 2026.
Organoids, as a groundbreaking biomedical research platform, utilize adult stem cells (ASCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs) as sources. By integrating specific growth and differentiation signals within an extracellular matrix (e.g., Matrigel), organoids guide cells to self‐assemble into three‐dimensional ...
Kelin Li, Rui Cao, Maochen Li, Zichao Tian, Huahao Fan, Bixia Hong, Xiaojuan Liu   +6 more
wiley   +1 more source